Lutronic Launches 'Ultra', US FDA-Cleared Laser Medical Device, in Korea

Lutronic laser medical device 'Ultra'
[Photo by Lutronic]

[Asia Economy Reporter Lee Gwan-ju] Lutronic announced on the 26th that it will launch the laser medical device 'Ultra,' which was first released in the United States, in South Korea as well.

This product was first launched overseas after obtaining approval from the U.S. Food and Drug Administration (FDA) in December 2019 and acquiring the European CE certification. In South Korea, it received approval from the Ministry of Food and Drug Safety in 2020.

Ultra is a Thulium Laser with a wavelength of 1927 nm. When irradiated on the skin surface, the moisture present in the stratum corneum evaporates, forming micro-perforations, which can be used to assist in skin tissue incision, removal, and drug absorption.

Compared to the previous model, it features ▲ a new tip (C5) ▲ enlarged beam size ▲ higher power (20W) ▲ and a uniform Top Hat Beam Profile. These improvements enable faster and more uniform energy delivery than the existing product.

A Lutronic official stated, "Since the previous Thulium Laser received positive responses overseas, we planned a sales strategy to introduce Ultra to the overseas market first," adding, "There have been many inquiries about Ultra's domestic launch, so it naturally led to its launch in South Korea as well." He further added, "As the convenience of use for doctors has increased, patients receiving treatments are also expected to have a better experience."

This content was produced with the assistance of AI translation services.